165 related articles for article (PubMed ID: 28482727)
21. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients.
Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Knogler T; Sillaber C; Jaeger U; Simonitsch-Klupp I; Ubl P; Müllauer L; Dolak W; Lukas J; Raderer M
Clin Cancer Res; 2015 Jun; 21(11):2506-13. PubMed ID: 25733598
[TBL] [Abstract][Full Text] [Related]
22. High-grade B-cell lymphoma relapse presenting as neurolymphomatosis of the median nerve.
Tai R; Maingard J; Nambiar M; Lim K
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30846458
[TBL] [Abstract][Full Text] [Related]
23. Primary lymphoma involving cranial nerves and cauda equina detected by (18)F-FDG PET/CT and MRI.
Wang G; Liu Y; He F
Nuklearmedizin; 2016 Sep; 55(5):N46-8. PubMed ID: 27668300
[No Abstract] [Full Text] [Related]
24. Sciatic nerve neurolymphomatosis - extent and therapy response assessment with PET/CT.
Strobel K; Fischer K; Hany TF; Poryazova R; Jung HH
Clin Nucl Med; 2007 Aug; 32(8):646-8. PubMed ID: 17667443
[TBL] [Abstract][Full Text] [Related]
25. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
26. Post-therapy lesions in patients with non-Hodgkin's lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm.
Radhakrishnan RK; Mittal BR; Basher RK; Prakash G; Malhotra P; Kalra N; Das A
Nucl Med Commun; 2018 Jan; 39(1):74-82. PubMed ID: 29189443
[TBL] [Abstract][Full Text] [Related]
27. A case of cranial multinevritis: from the onset to the diagnosis of primary neurolymphomatosis.
Vecchio D; Mittino D; Terazzi E; Nassi L; Conconi A; Monaco F
BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22707692
[TBL] [Abstract][Full Text] [Related]
28. [Neurolymphomatosis, a case report].
Bi HY; Na J; Zang GM; Zhang W; Yuan Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):331. PubMed ID: 15968331
[TBL] [Abstract][Full Text] [Related]
29. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
[TBL] [Abstract][Full Text] [Related]
30. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis.
Kanter P; Zeidman A; Streifler J; Marmelstein V; Even-Sapir E; Metser U; Stein GY; Cohen AM
Eur J Haematol; 2005 Jan; 74(1):66-9. PubMed ID: 15613109
[TBL] [Abstract][Full Text] [Related]
31. Diffuse large B-cell lymphoma relapse presenting as extensive neurolymphomatosis.
Nepal P; Batchala PP; Rehm PK; Fadul CE
Neuroradiol J; 2020 Jun; 33(3):230-235. PubMed ID: 32401669
[TBL] [Abstract][Full Text] [Related]
32. Beta-2 microglobulin as a diagnostic parameter in non-Hodgkin lymphoma: a comparative study with FDG-PET.
Toth DF; Raderer M; Wadsak W; Karanikas G
Anticancer Res; 2013 Aug; 33(8):3341-5. PubMed ID: 23898101
[TBL] [Abstract][Full Text] [Related]
33. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M
Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
[TBL] [Abstract][Full Text] [Related]
34. Fluorothymidine PET/CT in neurolymphomatosis.
Biswal CK; Mittal BR; Shukla J; Vatsa R; Bhattacharya A; Prabhakar S
Clin Nucl Med; 2015 May; 40(5):e290-2. PubMed ID: 25546221
[TBL] [Abstract][Full Text] [Related]
35. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era.
Khurana A; Novo M; Nowakowski GS; Ristow KM; Spinner RJ; Hunt CH; King RL; Lachance DH; Habermann TM; Micallef IN; Johnston PB
Blood Adv; 2021 Mar; 5(5):1379-1387. PubMed ID: 33661298
[TBL] [Abstract][Full Text] [Related]
36. The Role of FDG-PET in the Diagnosis and Staging of Ocular Adnexal Lymphoproliferative Disease.
English JF; Sullivan TJ
Orbit; 2015; 34(5):284-91. PubMed ID: 26308502
[TBL] [Abstract][Full Text] [Related]
37. Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients.
Atkinson W; Catana C; Abramson JS; Arabasz G; McDermott S; Catalano O; Muse V; Blake MA; Barnes J; Shelly M; Hochberg E; Rosen BR; Guimaraes AR
Abdom Radiol (NY); 2016 Jul; 41(7):1338-48. PubMed ID: 27315095
[TBL] [Abstract][Full Text] [Related]
38. Neurological picture. Neurolymphomatosis as the primary presentation of non-Hodgkin's Lymphoma.
Tsai HH; Chen YF; Hsieh ST; Chao CC
J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):929-30. PubMed ID: 25053772
[No Abstract] [Full Text] [Related]
39. Peripheral nerve neurolymphomatosis: Clinical features, treatment, and outcomes.
Keddie S; Nagendran A; Cox T; Bomsztyk J; Jaunmuktane Z; Brandner S; Manji H; Rees JH; Ramsay AD; Rossor A; D'Sa S; Reilly MM; Carr AS; Lunn MP
Muscle Nerve; 2020 Nov; 62(5):617-625. PubMed ID: 32786031
[TBL] [Abstract][Full Text] [Related]
40. An Extremely Rare Intersection: Neurolymphomatosis in a Patient with Burkitt Lymphoma Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Oner AO; Okuyucu K; Alagoz E; Battal B; Arslan N
World J Nucl Med; 2016 Sep; 15(3):209-11. PubMed ID: 27651745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
